Amitriptyline

This classification denotes a tricyclic antidepressant with the molecular formula C20H23N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1806D8D52K, chemically known as 10,11-dihydro-n,n-dimethyl-5h-dibenzo(a,d)heptalene-delta(sup 5),gamma-propylamine but generally known as amitriptyline, which bears US NIH Compound Identifier 2160. Amitriptyline most often comes in base, chloride, hydrochloride, n-glucuronide, and n-oxide forms. European Medicines Agency schedules Amitriptyline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05462MIG. The term AMITRIPTYLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules amitriptyline in its Anatomical Therapeutic Chemical (ATC) Classification. AMITRIPTYLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amitriptyline under HS 29214980 and SITC 51454. As of Q4 2014, AMITRIPTYLINE remains the US FDA Preferred Term for this commodity. Amitriptyline bears US NLM identifiers UMLS ID C0002600 and NCI Concept Code C62005. SMILES: N(CC/C=C1\c2c(CCc3c1cccc3)cccc2)(C)C.